Cialis

6,378 views

Published on

Created by Syndicate 4, MBA ITB 46A

Published in: Education
2 Comments
1 Like
Statistics
Notes
  • Acheter cialis original en ligne sans ordonnance pas cher en France http://www.cialis-originals.com/
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Acheter cialis original en ligne sans ordonnance pas cher en France http://www.cialis-originals.com/
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total views
6,378
On SlideShare
0
From Embeds
0
Number of Embeds
10
Actions
Shares
0
Downloads
197
Comments
2
Likes
1
Embeds 0
No embeds

No notes for slide
  • Variety of factor that ED patients want to seek treatment, with spouse or sex partners is the most highly cited (29%)
  • Younger man expressed higher level of embarrassment in talking about the condition and were waiting to go awayFor older men the belief that this was a normal phenomenon of aging seemed to create reluctance to seek treatmentFor those who seek treatment, Viagra was the most commonly suggested medication.
  • As we can see, the Viagra current users and viagra dropout has a large percentage that represent they willing to try Cialis in U.S and Europe
  • Drug store & Pharmaceutical StoreEasier for customer to fill the prescription after consulting with physician.Doctor ClinicHelping the consumer who get confuse about the medicine so they can get the right prescription after consulting with physician. Online Pharmacy : facilitate the ED patient who couldn’t go to local drugstore or find Cialis by simply fill it online.
  • Cialis

    1. 1. Background
    2. 2. ••••
    3. 3. 1990199820012002
    4. 4. 
    5. 5. Competitor Analysis
    6. 6. 
    7. 7. ¸¸¸¸¸
    8. 8. ED Market Share
    9. 9. Physicians•••
    10. 10. Patients•••
    11. 11. Average Age of ED Patients 60 58 Family doctor3% 5% 0% 56 Urologist or men`s specialist 49% 5443% Cardiologist 58.4 52 56.9 Psychiatrist 55.4 50 53.5 Internet doctor 50.7 50.7 48 46 US France Germany Italy Spain UK
    12. 12. Health Care Transaction Model (HCTM)• Perceived Consult their Actually take Intend to Receive a Fill the they have doctor about the refill perception perception condition condition medication prescription•••
    13. 13. My spouse or sex patner Newspaper or magazine 22% 29% TV, radio or movie commercial1% 2% A TV or radioshow2% 6% 15% A newspaper or magazine ad 3% 5% 2% 9% 4% A friend or relative Something that was mailed to me A sex counselor or psychologist
    14. 14. Barriers to Seeking Treatment Barriers to Seeking Treatment (ages 20-39) (ages 40-49) Waiting to see if the Waiting to see if the condition will go condition will go away 3% 7% away 9% 3% 14% 21% Doesn`t happen all 18% Doesn`t happen all that3% 5% that often often5% 6% 21% 15% 21% Embarrassed to talk 10% Embarrassed to talk 16% 19% about it 4% about it Don`t want to take Don`t want to take drugs for this drugs for this condition condition Barriers to Seeking Treatment Barriers to Seeking Treatment (ages 50-59) (ages 60+) Waiting to see if the Waiting to see if the condition will go 11% 8% condition will go away 20% 21% away 32%5% 10% Doesn`t happen all Doesn`t happen all that 18% that often often7% 14% 10% 13% 12%1% Embarrassed to talk 8% Embarrassed to talk 5% about it about it 3% 3%
    15. 15. USFranceGermanyItalySpainUK
    16. 16. 
    17. 17. Problem Analysis
    18. 18.  How Cialis gain market share and compete with existing market leader Viagra? Should Cialis be priced higher or lower than Viagra? How Cialis choosing the strategy to compete with Viagra : - Niche strategy - Direct compete (head to head competition) - Beat strategy (differential Positioning)
    19. 19. SWOT AnalysisS WTRENGTHS EAKNESSES • The absorption of the drug was not affected by food • Cialis is a new entrance intake • Low Compound Annual • Cialis has a shorter onset Growth Rates (CAGR) in time and the effects up to Germany and France. 36 hours. This may lead to low • Rare incidence of visual return in these markets. irregularities • The banned direct-to- Internal • Record submission time of consumer in Europe factors Phase III to FDA will lead to inconsistency • Has a great Global in the marketing and Marketing Sales organization present greater difficulties to improve Cialis in targeting in countries.O TPPORTUNITIES HREATS • High CAGR n the US, UK, Italy, Spain, Canada , Mexico and Brazil. There is •Viagra and Levitra as a opportunity to gain market current competitor share in these regions. •Upcoming new competitor • The high dropout rates of •Bad experience of using External Viagra after first year offers Cialis factors potential targeting for Lilly •Barriers to seeking ICOS LLC. treatment • Current Viagra users and •Viagra well positioned and dropouts user willing to try well known, but Cialis Cialis unknown • Positioning by considering love and intimacy
    20. 20. STP Cialis •Age : •Core Target Age • Men with Erectile Dysfunction in  50 – 59, 60+ ageSegmenting Positioning • Cialis, for male United States and Europe Targeting (France, Germany, Italy, Spain, and United Kingdom) and age 20 – 65 group years old. •Additional Target who suffer from Age  20 – 39 Erectile •Income : Middle to Dysfunction will Low help you to be •Employment : more intimate Employed full time with your partner and retired and quality of life •Marital status because of its durability, shorter •Primary : Married or Living together onset and (76,5%) flexibility with meal taken. •Secondary : Single, Never married (10,5%) & Divorce or separated (10,3%)
    21. 21. Product ProductBrand name : CialisForm : TabletServing size : 10 mg, 20 mgCialis is only available with a prescription and have to consult with Primarycare physician/ urologist first.
    22. 22. Product Price Slightly lower than Viagra ($10/pill) Cialis set the price on $ 9 / pill To attract people that Cialis is better than Viagra even the price is less. It has better durability and more safety because all product are sell with doctor prescription.
    23. 23. Product Price  Net Sales GrowthNet Sales 1996 1997 1998 1999 2000 AverageGrowth Net SalesPercentage - 15,9% 8,4% 7,32% 9,58% 10,3%GrowthIn Millions 7.346,6 8.517,6 9.236,8 9.912,9 10.862,2 -  ForecastForecast Net Year 1 Year 2 Year 3 (15% Year 4 (20% Year 5 (25%Sales (From Growth) Growth) Growth)average 10,3%)In Millions 11.948,2 13.178,9 15.155.735 18.186,9 22.733,6
    24. 24. Product Place☺Drug store☺Clinical Pharmacy☺Hospital Pharmacy☺ Online Pharmacy
    25. 25. PromotionBelow the line••
    26. 26. PromotionAbove the line
    27. 27. PromotionAbove the line
    28. 28. PromotionAbove the line  
    29. 29. PromotionAbove the line    
    30. 30. CONCLUSION

    ×